Chlamydia Trachomatis

Chlamydia knocks out the body's own cancer defence

Infections due to the sexually transmitted bacterium Chlamydia trachomatis often remain unnoticed. The pathogen is not only a common cause of female infertility; it is also suspected of increasing the risk of abdominal cancer. ...

Nov 14, 2014
popularity0 comments 0

Paternal exposures can adversely affect sperm

Acording to the California Teratogen Information Service (CTIS) Pregnancy Health Information Line, more studies are needed to evaluate men and the potential effect of illnesses, medications and lifestyle habits on fertility ...

Jun 20, 2011
popularity0 comments 0

Chlamydia trachomatis, an obligate intracellular human pathogen, is one of three bacterial species in the genus Chlamydia. C. trachomatis is a Gram-negative bacteria, therefore its cell wall components retain the counter-stain safranin and appear pink under a light microscope.

The inclusion bodies of Chlamydia trachomatis were first described in 1907, the Chlamydia trachomatis agent was first cultured in the yolk sacs of eggs by Feifan Tang et al in 1957.

Chlamydial infection. Advances in the diagnostic isolation of Chlamydia, including TRIC agent, from the eye, genital tract, and rectum.

C. trachomatis includes three human biovars:

Many, but not all, C. trachomatis strains have an extrachromosomal plasmid.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Improved memory thanks to irregular sleep-wake patterns

If you've had a good night's sleep, you are mentally more alert and your memory works more reliably. During sleep, a part of our forebrain called the prefrontal cortex remains active. It ensures that memories and learned ...

How to become a T follicular helper cell

Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong and lasting antibody response to viruses and other microbes, have garnered intense interest in recent years but the ...

HVTN 505 vaccine induced antibodies nonspecific for HIV

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

A cheaper, high-performance prosthetic knee

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...